James Legg will speak on the first day of the ADC Summit 2015, which takes place on 18-19 May 2015 in London. The conference will focus on recent technical developments in relation to Antibody Drug Conjugate (ADC) therapeutics and will be attended by leading individuals from academia, biotech and pharma.
The multifaceted nature of ADC therapeutics presents challenges and opportunities for developing a robust IP position. James will speak on the topic of ‘Using IP to benefit from ADC technologies’, covering data requirements for ADC patents and when to file a patent application, freedom to operate challenges and how to benefit from IP transactions.
Read more about the conference here.